Malignant mixed mullerian tumor: An immunohistochemical study

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Bing, Zhanyong ^a   Pasha, Theresa ^a   Wang, Li Ping ^a   Zhang, Paul J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866253152     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/569609     Document Type: Article

References (30)

1. Navarini R., Pineda R. L., Malignant mixed müllerian tumors of the ovary. Current Opinion in Obstetrics and Gynecology 2006 18 1 20 23 2-s2.0-33646466794 10.1097/01.gco.0000192997.27663.9e
2. Muntz H. G., Jones M. A., Goff B. A., Malignant mixed mullerian tumors of the ovary: experience with surgical cytoreduction and combination chemotherapy. Cancer 1995 76 7 1209 1213 10.1002/1097-0142(19951001)76:71209::AID- CNCR2820760717>3.0.CO;2-V
3. Bing Z., Pasha T., Tomaszewski J. E., Zhang P., CDX2 expression in yolk sac component of testicular germ cell tumors. International Journal of Surgical Pathology 2009 17 5 373 377 2-s2.0-70349546316 10.1177/1066896909338598
4. Kammerer-Doak D., Baurick K., Black W., Barbo D. M., Smith H. O., Endodermal sinus tumor and embryonal carcinoma of the ovary in a 53- year-old woman. Gynecologic Oncology 1996 63 1 133 137 2-s2.0-0030272466 10.1006/gyno.1996.0292 (Pubitemid 26337980)
5. Mazur M. T., Talbot W. H. Jr., Talerman A., Endodermal sinus tumor and mucinous cystadenofibroma of the ovary. Occurrence in an 82-year-old woman. Cancer 1988 62 9 2011 2015 2-s2.0-0023806644 (Pubitemid 18261829)
6. Oh C., Kendler A., Hernandez E., Ovarian endodermal sinus tumor in a postmenopausal woman. Gynecologic Oncology 2001 82 2 392 394 2-s2.0-0034898069 10.1006/gyno.2001.6286 (Pubitemid 32730626)
7. Clement P. B., Young R. H., Scully R. E., Endometrioid-like variant of ovarian yolk sac tumor. A clinicopathological analysis of eight cases. American Journal of Surgical Pathology 1987 11 10 767 778 2-s2.0-0023231505 (Pubitemid 17143583)
8. Cao D., Guo S., Allan R. W., Molberg K. H., Peng Y., SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. American Journal of Surgical Pathology 2009 33 6 894 904 2-s2.0-67549105495 10.1097/PAS.0b013e318198177d
9. Kobayashi D., Kuribayshi K., Tanaka M., Watanabe N., SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer. International Journal of Oncology 2011 38 4 933 939 2-s2.0-79952338489 10.3892/ijo.2011.929
10. Lu J., Ma Y., Kong N., Alipio Z., Gao C., Krause D. S., Silberstein L. E., Chai L., Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia. Leukemia 2011 25 7 1211 1213 2-s2.0-79960268598 10.1038/leu.2011.65
11. Jurgens G., Head and tail development of the Drosophila embryo involves spalt, a novel homeotic gene. The EMBO Journal 1988 7 189 196
12. Kohlhase J., Heinrich M., Schubert L., Southam L., Hugill A., Golamaully M., Cooper R., Adeyemo A., Soubrier F., Ward R., Lathrop G. M., Matsuda F., Farrall M., Okihiro syndrome is caused by SALL4 mutations. Human Molecular Genetics 2002 11 23 2979 2987 (Pubitemid 35331829)
13. Zhang J., Tam W. L., Tong G. Q., Wu Q., Chan H. Y., Soh B. S., Lou Y., Yang J., Ma Y., Chai L., Ng H. H., Lufkin T., Robson P., Lim B., Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nature Cell Biology 2006 8 10 1114 1123 2-s2.0-33749173803 10.1038/ncb1481 (Pubitemid 44473607)
14. Kobayashi D., Kuribayashi K., Tanaka M., Watanabe N., Overexpression of SALL4 in lung cancer and its importance in cell proliferation. Oncology Reports 2011 26 4 965 970 2-s2.0-79960831107 10.3892/or.2011.1374
15. Gao C., Kong N. R., Chai L., The role of stem cell factor SALL4 in leukemogenesis. Critical Reviews in Oncogenesis 2011 16 1-2 117 127
16. Deisch J., Raisanen J., Rakheja D., Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors. Pediatric and Developmental Pathology 2011 14 5 353 359 10.2350/10-09-0902-OA.1
17. Deisch J., Raisanen J., Rakheja D., Immunoexpression of SALL4 in wilms tumors and developing kidney. Pathology and Oncology Research 2011 17 639 644 2-s2.0-78651539845 10.1007/s12253-011-9364-0
18. Kekuda R., Prasad P. D., Wu X., Wang H., Fei Y. J., Leibach F. H., Ganapathy V., Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. Journal of Biological Chemistry 1998 273 26 15971 15979 2-s2.0-0032569029 10.1074/jbc.273.26.15971 (Pubitemid 28311362)
19. Cheng L., Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 2004 101 9 2006 2010 2-s2.0-7044226225 10.1002/cncr.20566 (Pubitemid 39425376)
20. Huang P., Chen J., Wang L., Na Y., Kaku H., Ueki H., Sasaki K., Yamaguchi K., Zhang K., Saika T., Nasu Y., Watanabe M., Kumon H., Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence. Medical Oncology 2012 29 829 834 10.1007/s12032-011-9962-4
21. Rao P., Tannir N. M., Tamboli P., Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfall. American Journal of Surgical Pathology 2012 36 4 583 588 10.1097/PAS.0b013e3182417d78
22. Jordan C. T., Guzman M. L., Noble M., Cancer stem cells. New England Journal of Medicine 2006 355 12 1253 1261 2-s2.0-33748891391 10.1056/NEJMra061808 (Pubitemid 44427449)
23. Xiang Y. Y., Ladeda V., Filmus J., Glypican-3 expression is silenced in human breast cancer. Oncogene 2001 20 50 7408 7412 2-s2.0-0035504922 10.1038/sj.onc.1204925 (Pubitemid 33078211)
24. Sugimura J., Foster R. S., Cummings O. W., Kort E. J., Takahashi M., Lavery T. T., Furge K. A., Einhorn L. H., Teh B. T., Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis. Clinical Cancer Research 2004 10 7 2368 2378 2-s2.0-1842426585 10.1158/1078-0432.CCR-03-0341 (Pubitemid 38445695)
25. Zynger D. L., Everton M. J., Dimov N. D., Chou P. M., Yang X. J., Expression of glypican 3 in ovarian and extragonadal germ cell tumors. American Journal of Clinical Pathology 2008 130 2 224 230 2-s2.0-48649084091 10.1309/8DN7DQRDFB4QNH3N
26. Stainier D. Y. R., No organ left behind: tales of gut development and evolution. Science 2005 307 5717 1902 1904 2-s2.0-15544378302 10.1126/science.1108709 (Pubitemid 40404691)
27. Bakaris S., Cetinkaya A., Ezberci F., Ekerbicer H., Expression of homeodomain protein CDX2 in colorectal adenoma and adenocarcinoma. Histology and Histopathology 2008 23 79 1043 1047 2-s2.0-48049093900
28. Hocking G. R., Shembrey M., Hay D., Ostor A. G., Alpha-fetoprotein- producing adenocarcinoma of the sigmoid colon with possible hepatoid differentiation. Pathology 1995 27 3 277 279 2-s2.0-0028803329 10.1080/00313029500169113
29. Kurihara K., Konishi F., Kanazawa K., Fujii T., Saito K., Alpha-fetoprotein-producing carcinoma of the colon: report of a case. Surgery Today 1997 27 5 453 456 2-s2.0-0030919718 10.1007/BF02385712 (Pubitemid 27212585)
30. Ucar E., Semerci E., Ustun H., Yetim T., Huzmeli C., Gullu M., Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Advances in Therapy 2008 25 10 1075 1084 2-s2.0-61749094899